The Diagnostic Validity and Clinical Impact of Blood-based Biomarkers for the Diagnosis of Alzheimer's Disease at the Primary Care Level.
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this study is to determine how blood biomarker tests (ptau217 and ptau217/Aβ42) performed in primary care influence the patient trajectory in individuals with cognitive concerns. Participants will provide a blood sample for biomarker testing and undergo clinical assessments as part of diagnostic evaluation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Maximum Age: 85
Healthy Volunteers: t
View:
• Patients between 55 and 85 years old who consult their PCP due to concerns about their cognitive status.
Locations
Other Locations
Belgium
UZ Leuven/KU Leuven
RECRUITING
Leuven
Time Frame
Start Date: 2026-05-26
Estimated Completion Date: 2038-04
Participants
Target number of participants: 240
Treatments
Other: All participants
All participants will get ptau217 measurements.
Related Therapeutic Areas
Sponsors
Leads: Universitaire Ziekenhuizen KU Leuven